AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
IVAX Corp. (4400 Biscayne Blvd., Miami, FL 33137; Tel: 305/575- 6000, Fax: 305/575-6055) has entered into an agreement to acquire substantially all of the products comprising the generic pharmaceutical business of Merck & Co.'s (P.O. Box 100, Whitehouse Station, N.J. 08889-0100; Tel: 908/423-1000) Merck Sharp & Dohme subsidiary in France. The transaction is subject to the transfer by the Agence Francaise de Securite Sanitaire des Produits de Sante of the applicable marketing authorizations to IVAX' French subsidiary.
"As we continue to expand our global pharmaceutical business, this transaction will provide us with an immediate generic product line in …